SCHEMBL6153841

SCHEMBL6153841

CCCCOc1ccc(-c2nnc(Nc3ccc(Cl)c(Cl)c3)s2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.72
RAB9A P51151 2/20 0.53
LMNA P02545 2/20 0.53
MAPT P10636 2/20 0.53
MEN1 O00255 3/20 0.51
POLB P06746 3/20 0.51
KMT2A Q03164 3/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
XIAP P98170 1/20 0.51
BLM P54132 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 2/20 0.47
NPC1 O15118 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PIK3CD O00329 1/20 0.46
PIK3CA P42336 1/20 0.46
PIK3CB P42338 1/20 0.46
HPN P05981 1/20 0.45
AGER Q15109 1/20 0.43
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6154727 0.81 GUSB (0.61) GUSBRAB9AMAPTMEN1POLB
SCHEMBL6155706 0.79 GUSB (0.72) GUSBLMNAMAPTMEN1POLB
SCHEMBL6153932 0.79 GUSB (0.72) GUSBRAB9ALMNAMAPTMEN1
SCHEMBL6154672 0.78 GUSB (0.61) GUSBRAB9AMAPTMEN1POLB
SCHEMBL6155747 0.77 GUSB (0.70) GUSBRAB9ALMNAMAPTMEN1
SCHEMBL6154782 0.77 GUSB (0.69) GUSBRAB9ALMNAMAPTMEN1
SCHEMBL6156037 0.77 GUSB (0.69) GUSBRAB9ALMNAMAPTMEN1
SCHEMBL6154349 0.75 GUSB (0.60) GUSBLMNAMEN1POLBKMT2A
SCHEMBL6153939 0.75 GUSB (0.56) GUSBRAB9ALMNAMAPTMEN1
SCHEMBL14016479 0.74 RAB9A (0.53) RAB9ALMNAMAPTXIAPSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US claimed
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP GUSB 2466/4885RAB9A 3814/4885LMNA 4884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.